DrugPatentWatch Database Preview
FLUORODOPA F18 Drug Profile
» See Plans and Pricing
When do Fluorodopa F18 patents expire, and what generic alternatives are available?
Fluorodopa F18 is a drug marketed by Feinstein and is included in one NDA.
The generic ingredient in FLUORODOPA F18 is fluorodopa f-18. One supplier is listed for this compound. Additional details are available on the fluorodopa f-18 profile page.
Summary for FLUORODOPA F18
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 6 |
| Clinical Trials: | 10 |
| Patent Applications: | 2 |
| DailyMed Link: | FLUORODOPA F18 at DailyMed |
Generic Entry Opportunity Date for FLUORODOPA F18
Generic Entry Date for FLUORODOPA F18*:
Constraining patent/regulatory exclusivity:
FDA exclusivity NDA:
Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for FLUORODOPA F18
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Thomas Jefferson University | Phase 2 |
| Washington University School of Medicine | Phase 1 |
| Erik Mittra | N/A |
US Patents and Regulatory Information for FLUORODOPA F18
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feinstein | FLUORODOPA F18 | fluorodopa f-18 | SOLUTION;INTRAVENOUS | 200655-001 | Oct 10, 2019 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
